SOCIETY FOR VASCULAR SURGERY

Lobbying for SOCIETY FOR VASCULAR SURGERY

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$90,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

LYNDON KYLE GERRON

Previously held: Rep. Joe Barton (R-TX)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 11

Centers For Disease Control & Prevention (CDC)
Centers For Medicare and Medicaid Services (CMS)
Education, Dept of
Federal Trade Commission (FTC)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Labor, Dept of (DOL)
Natl Institutes of Health (NIH)
SENATE
Treasury, Dept of

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 19

HR 879
Medicare Patient Access and Practice Stabilization Act of 2025
S 1640
Medicare Patient Access and Practice Stabilization Act of 2025
HR 2433
Reducing Medically Unnecessary Delays in Care Act of 2025
HR 3514
Improving Seniors’ Timely Access to Care Act of 2025
S 1816
Improving Seniors’ Timely Access to Care Act of 2025
HR 539
Chiropractic Medicare Coverage Modernization Act of 2025
S 106
Chiropractic Medicare Coverage Modernization Act of 2025
HR 4731
Resident Physician Shortage Reduction Act of 2025
S 2439
Resident Physician Shortage Reduction Act of 2025
HR 4681
SPARC Act
S 1380
SPARC Act
HR 7520
Efficiency Adjustment Delay Act
HR 1616
Promoting Access to Diabetic Shoes Act
S 1805
Promoting Access to Diabetic Shoes Act
HR 8163
Provider Reimbursement Stability Act of 2026
S 266
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
HR 929
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
S 942
REDI Act
HR 2028
REDI Act

Lobbying activity 4

Medicare/Medicaid

Medicare Physician Payment Reform; in general; Mitigating cuts for Medicare Part B cuts; in general; Concerns regarding Expansion of Prior Authorization in Medicare FFS; H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act; H.R. 2433, the Reducing Medically Unnecessary Delays in Care Act of 2025; H.R. 3514/S.1816, the Improving Seniors Timely Access to Care Act of 2025; H.R. 539/S. 106, the Chiropractic Medicare Coverage Modernization Act; H.R. 4731/S. 2439, Resident Physician Shortage Reduction Act of 2025; H.R. 4681/S. 1380, the Specialty Physicians Advancing Rural Care (SPARC) Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 1616/S. 1805, the Promoting Access to Diabetic Shoes Act; H.R. 8163, the Provider Reimbursement Stability Act of 2026

Budget/Appropriations

Support for continued funding for medical research; Support for continued funding for health-related agencies; Issues relating to FY27 appropriations re: healthcare

Health Issues

S. 266/H.R. 929, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Issues relating to the Administration's "Make America Healthy Again" initiative

Education

Preserving Federal Loan Access for Physicians and Other Health Professionals Under OBBBA Implementation; S. 942/H.R. 2028, the Resident Education Deferred Interest (REDI) Act; H.R. 4681/S. 1380, the Specialty Physicians Advancing Rural Care (SPARC) Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.